seven infants ( group 1 ) received indomethacin to treat a clinically significant patent ductus arteriosus ( pda ) , and eight infants ( group 2 ) received indomethacin prophylactically at 24 hours of age because of their high risk for pda .
C0021246
indomethacin
C0013274
pda